SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-19-007503
Filing Date
2019-02-14
Accepted
2019-02-14 06:08:19
Documents
1
Group Members
DANIEL MACKWILMOT B. HARKEY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv513646_sc13ga.htm SC 13G/A 65456
  Complete submission text file 0001144204-19-007503.txt   67102
Mailing Address 19 OLD KINGS HIGHWAY S SUITE 200 DARIEN CT 06820
Business Address 19 OLD KINGS HIGHWAY S SUITE 200 DARIEN CT 06820 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

IRS No.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 19600380
SIC: 2834 Pharmaceutical Preparations